PharmaKure Submits MHRA CTA for Phase 2a Clinical Trial of PK051 in Patients with Mild Cognitive Impairment Read More » October 24, 2023
Oncolytics Biotech Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO Read More » October 23, 2023
New Phase 3 TREMFYA® (guselkumab) Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response Rate and Early Symptom Improvement Read More » October 23, 2023
Aculys Pharma Delivers Positive Phase 3 Clinical Study Interim Analysis result of a Diazepam Nasal Spray | An Antiepileptic Drug for RX of Epileptic Seizures Read More » October 18, 2023
Brise Pharma Announces First Patient Dosed with BR01T in Phase I Study in Patients with Chronic Low Back Pain Read More » October 18, 2023